ASND vs. CAH: A Head-to-Head Stock Comparison
UpdatedHere’s a clear look at ASND and CAH, comparing key factors like performance, valuation metrics, dividends, and financial strength. It’s built for investors or anyone curious to see how these two stocks match up.
Company Overview
CAH stands out with 36.59 billion USD in market value—about 3.83× ASND’s market cap of 9.55 billion USD.
CAH carries a higher beta at 0.67, indicating it’s more sensitive to market moves, while ASND remains steadier at 0.40.
ASND trades as an ADR, giving U.S. investors a simple on-ramp to its foreign shares, while CAH remains a standard domestic listing.
Symbol | ASND | CAH |
---|---|---|
Company Name | Ascendis Pharma A/S | Cardinal Health, Inc. |
Country | DK | US |
Sector | Healthcare | Healthcare |
Industry | Biotechnology | Medical - Distribution |
CEO | Mr. Jan Moller Mikkelsen | Mr. Jason M. Hollar |
Price | 158.1 USD | 153.31 USD |
Market Cap | 9.55 billion USD | 36.59 billion USD |
Beta | 0.40 | 0.67 |
Exchange | NASDAQ | NYSE |
IPO Date | January 28, 2015 | August 4, 1983 |
ADR | Yes | No |
Performance Comparison
This chart compares the performance of ASND and CAH over the past year by tracking the growth of an initial $10,000 investment in each (starting one year ago).
Hover over the lines to see the investment’s value and total return (%) at specific dates.
Data is adjusted for dividends and splits.
Valuation Metrics Comparison
The section examines key financial ratios to assess the valuation of ASND and CAH based on earnings, cash flow, sales, and book value. Pay attention to the following notable points where extreme values stand out.
- ASND posts a negative P/E of -24.55, reflecting last year’s net loss, while CAH at 23.62 signals healthy earnings.
- ASND posts a negative forward PEG of -2.23, hinting at anticipated earnings decline, whereas CAH at 1.95 has projections for stable or growing earnings.
- Book value is underwater for both ASND (-44.19) and CAH (-12.48), meaning liabilities exceed assets—signaling a critical solvency risk for both companies.
- ASND has a negative Price-to-Free Cash Flow ratio of -27.43, signaling it consumed more cash than it produced over the last year—an important liquidity warning. In contrast, CAH (P/FCF 15.00) indicates positive free cash flow generation.
Symbol | ASND | CAH |
---|---|---|
Price-to-Earnings Ratio (P/E, TTM) | -24.55 | 23.62 |
Forward PEG Ratio (TTM) | -2.23 | 1.95 |
Price-to-Sales Ratio (P/S, TTM) | 22.88 | 0.16 |
Price-to-Book Ratio (P/B, TTM) | -44.19 | -12.48 |
Price-to-Free Cash Flow Ratio (P/FCF, TTM) | -27.43 | 15.00 |
EV-to-EBITDA (TTM) | -35.74 | 14.56 |
EV-to-Sales (TTM) | 23.78 | 0.18 |
EV-to-Free Cash Flow (TTM) | -28.50 | 16.79 |
Dividend Comparison
ASND offers a 0% dividend yield, suggesting it may be reinvesting available cash back into the business for future growth, while CAH provides a 1.32% dividend yield, giving investors a steady income stream.
Symbol | ASND | CAH |
---|---|---|
Dividend Yield (TTM) | 0.00% | 1.32% |
Financial Strength Metrics Comparison
This section dives into the financial resilience of ASND and CAH, spotlighting key metrics like liquidity, leverage, and debt coverage. Check out the standout observations below where notable differences or extremes pop up.
- CAH’s current ratio of 0.94 indicates its assets may not cover near-term debts, whereas ASND at 1.04 maintains healthy liquidity.
- Both ASND (quick ratio 0.71) and CAH (quick ratio 0.50) fall below 0.8, meaning their most liquid assets—excluding inventory—aren’t enough to meet short-term obligations. This could force them to rely on receivables, inventory turn, or external financing.
- Both ASND (debt-to-equity ratio -4.46) and CAH (-2.60) exhibit negative shareholder equity—assets fall short of liabilities—signaling serious balance-sheet stress.
- With negative EBIT (-3.72), ASND cannot cover its interest payments. CAH, with an interest coverage of 15.45, meets its interest obligations.
Symbol | ASND | CAH |
---|---|---|
Current Ratio (TTM) | 1.04 | 0.94 |
Quick Ratio (TTM) | 0.71 | 0.50 |
Debt-to-Equity Ratio (TTM) | -4.46 | -2.60 |
Debt-to-Assets Ratio (TTM) | 0.80 | 0.15 |
Interest Coverage Ratio (TTM) | -3.72 | 15.45 |